PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma

DOI PDF PDF Web Site Web Site ほか1件をすべて表示 一部だけ表示 被引用文献3件 参考文献38件 オープンアクセス

説明

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Small-cell lung carcinoma (SCLC) is a neuroendocrine tumor subtype and comprises approximately 15% of lung cancers. Because SCLC is still a disease with a poor prognosis and limited treatment options, there is an urgent need to develop targeted molecular agents for this disease.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>We screened 20 cell lines from a variety of pathological phenotypes established from different organs by RT-PCR. Paraffin-embedded tissue from 252 primary tumors was examined for PTPRZ1 expression using immunohistochemistry. shRNA mediated <jats:italic>PTPRZ1</jats:italic> down-regulation was used to study impact on tyrosine phosphorylation and <jats:italic>in vivo</jats:italic> tumor progression in SCLC cell lines.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Here we show that PTPRZ1, a member of the protein tyrosine- phosphatase receptor (PTPR) family, is highly expressed in SCLC cell lines and specifically exists in human neuroendocrine tumor (NET) tissues. We also demonstrate that binding of the ligand of PTPRZ1, pleiotrophin (PTN), activates the PTN/PTPRZ1 signaling pathway to induce tyrosine phosphorylation of calmodulin (CaM) in SCLC cells, suggesting that PTPRZ1 is a regulator of tyrosine phosphorylation in SCLC cells. Furthermore, we found that PTPRZ1 actually has an important oncogenic role in tumor progression in the murine xenograft model.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>PTPRZ1 was highly expressed in human NET tissues and PTPRZ1 is an oncogenic tyrosine phosphatase in SCLCs. These results imply that a new signaling pathway involving PTPRZ1 could be a feasible target for treatment of NETs.</jats:p> </jats:sec>

収録刊行物

  • BMC Cancer

    BMC Cancer 12 (1), 537-, 2012-11-21

    Springer Science and Business Media LLC

被引用文献 (3)*注記

もっと見る

参考文献 (38)*注記

もっと見る

関連プロジェクト

もっと見る

問題の指摘

ページトップへ